Lifarizine

DB20533ExperimentalSmall molecule

Lifarizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Lifarizine is a antihistaminic/cerebral (or peripheral) vasodilator. Lifarizine has a monoisotopic molecular...

Mechanism: Pharmacologically active on Voltage-gated sodium channel alpha subunit
Curator reviewed
Formula / weight: C₂₉H₃₂N₄ · 436.603 g/mol (avg)
Code names: RS-87476-000

Resolves to

Compound

UNIIC3705I245KCAS119514-66-8ChEMBLCHEMBL122079ChEBI177661PubChem71336

Structure

InChIKeyHTDFEXRUDGWNHA-UHFFFAOYSA-NSMILESCC1=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=CC=C2)N=C(N1)C1=CC=C(C)C=C1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Lifarizine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account